Skip to Content
Is your RA under control? Take an assessment here >

Rofecoxib Pregnancy and Breastfeeding Warnings

Rofecoxib is also known as: Vioxx

Rofecoxib Pregnancy Warnings

Merck pharmaceuticals encourages healthcare providers to report any prenatal exposure to rofecoxib by calling the Pregnancy Registry at (800)-986-8999. The registry has been created to monitor the pregnancy outcomes of women exposed to rofecoxib while pregnant.

Rofecoxib has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. Data from human pregnancy studies are not available. Rofecoxib should only be given during pregnancy when benefit outweighs risk. The manufacturer recommends that rofecoxib be avoided in late pregnancy (third trimester) due to the risk of premature closure of the ductus arteriosus.

See references

Rofecoxib Breastfeeding Warnings

There is no data on the excretion of rofecoxib into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Vioxx (rofecoxib)." Merck & Co, Inc, West Point, PA.

References for breastfeeding information

  1. "Product Information. Vioxx (rofecoxib)." Merck & Co, Inc, West Point, PA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.